【摘要】：目的針對脈搏指示連續(xù)心輸出量測定(PiCCO)監(jiān)測技術(shù)在感染性休克患者液體復(fù)蘇及血管活性藥物應(yīng)用中的指導(dǎo)作用進(jìn)行研究,為患者病情觀察治療方案制定的監(jiān)測方法的選擇提供依據(jù)。方法選擇2012年12月-2015年9月醫(yī)院收治的感染性休克患者120例,隨機(jī)分為對照組和觀察組,各60例;對照組患者實(shí)施EGDT方案指導(dǎo)液體復(fù)蘇,觀察組患者采用PiCCO監(jiān)測技術(shù)指導(dǎo)液體復(fù)蘇;對兩組患者的復(fù)蘇、血管活性藥物的使用、治療效果等進(jìn)行對比分析;采用SPSS16.5軟件對數(shù)據(jù)進(jìn)行統(tǒng)計(jì)分析。結(jié)果觀察組患者的血管活性藥物的應(yīng)用與對照組比較,差異有統(tǒng)計(jì)學(xué)意義(P0.05);觀察組患者的APACHEⅡ評分與對照組患者比較,差異有統(tǒng)計(jì)學(xué)意義(P0.05);觀察組患者的PaO2/FiO2與對照組比較,差異有統(tǒng)計(jì)學(xué)意義(P0.05);觀察組患者的復(fù)蘇成功率為83.33%,對照組的復(fù)蘇成功率為66.67%,差異有統(tǒng)計(jì)學(xué)意義(P0.05);觀察組患者的ICU留置時(shí)間、機(jī)械通氣時(shí)間、達(dá)到早期復(fù)蘇目標(biāo)(EGDT)時(shí)間、液體復(fù)蘇時(shí)間與對照組比較,差異有統(tǒng)計(jì)學(xué)意義(P0.05);觀察組患者肺水腫發(fā)生率和病死率與對照組比較,差異均有統(tǒng)計(jì)學(xué)意義(P0.05);觀察組患者的乳酸水平、排尿量、ScvO2水平與對照組比較,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論感染性休克患者在PiCCO監(jiān)測技術(shù)下,液體復(fù)蘇效果較好,對患者的血管活性藥物的使用有積極的指導(dǎo)作用,值得在臨床上進(jìn)行推廣。
[Abstract]:Objective to study the guiding role of pulse indicator continuous cardiac output (PiCCO) monitoring in fluid resuscitation and vasoactive drug use in septic shock patients. To provide a basis for the selection of monitoring methods for patients' disease observation and treatment. Methods 120 patients with septic shock from December 2012 to September 2015 were randomly divided into two groups: control group (n = 60) and observation group (n = 60). The patients in the control group were treated with EGDT regimen to guide fluid resuscitation, the patients in the observation group were treated with PiCCO monitoring technique, the patients in the two groups were resuscitated, the use of vasoactive drugs and the therapeutic effect were compared and analyzed. The data were analyzed by SPSS16.5 software. Results the use of vasoactive drugs in the observation group was significantly different from that in the control group (P0.05), the APACHE 鈪，

本文編號：2299458